We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+7.56%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$40.8B
AUM Growth
+$3.42B
(+9.2%)
Cap. Flow
+$1.07B
Cap. Flow
% of AUM
2.63%
Top 10 Holdings %
Top 10 Hldgs %
25.28%
Holding
2,151
New
303
Increased
1,108
Reduced
653
Closed
86
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
West Pharmaceutical
WST
|
+$197M |
| 2 |
Walmart Inc
WMT
|
+$193M |
| 3 |
NextEra Energy
NEE
|
+$177M |
| 4 |
Apple
AAPL
|
+$129M |
| 5 |
UnitedHealth
UNH
|
+$120M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$230M |
| 2 |
Sysco
SYY
|
+$164M |
| 3 |
Synopsys
SNPS
|
+$81.2M |
| 4 |
C.H. Robinson
CHRW
|
+$53.8M |
| 5 |
United Bankshares
UBSI
|
+$41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.01% |
| 2 | Consumer Staples | 11.62% |
| 3 | Industrials | 10.88% |
| 4 | Consumer Discretionary | 9.53% |
| 5 | Healthcare | 9.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1951
Lyell Immunopharma
LYEL
$309M
| $62.8K | ﹤0.01% |
2,275
+326
| +17% | +$9.58K |
|
1952
SmartRent
SMRT
$183M
| $62.5K | ﹤0.01% |
36,110
+10,950
| +44% | +$20.8K |
|
1953
Nano X Imaging
NNOX
$62.4M
| $62.3K | ﹤0.01% |
+10,248
| New | +$72.8K |
|
|
OLPX
1954
DELISTED
Olaplex Holdings
OLPX
| $61.6K | ﹤0.01% |
+26,200
| New | +$53.1K |
|
1955
Cerus
CERS
$587M
| $59.3K | ﹤0.01% |
34,097
+10,329
| +43% | +$21.7K |
|
1956
Safe Bulkers
SB
$781M
| $59.1K | ﹤0.01% |
+11,412
| New | +$58.7K |
|
|
ESPR
1957
DELISTED
Esperion Therapeutics
ESPR
| $58.9K | ﹤0.01% |
+35,706
| New | +$72.1K |
|
|
ILPT
1958
Industrial Logistics Properties Trust
ILPT
$613M
| $58.7K | ﹤0.01% |
+12,337
| New | +$58K |
|
1959
Navitas Semiconductor
NVTS
$2.66B
| $58.4K | ﹤0.01% |
23,840
+8,671
| +57% | +$28.2K |
|
|
NAPA
1960
DELISTED
The Duckhorn Portfolio, Inc.
NAPA
| $58.3K | ﹤0.01% |
+10,039
| New | +$66.1K |
|
1961
OraSure Technologies
OSUR
$273M
| $58.2K | ﹤0.01% |
+13,638
| New | +$58.6K |
|
1962
The RealReal
REAL
$1.34B
| $58.1K | ﹤0.01% |
+18,493
| New | +$55.6K |
|
|
LAZR
1963
DELISTED
Luminar Technologies
LAZR
| $57K | ﹤0.01% |
4,224
+1,624
| +62% | +$29.5K |
|
1964
Ribbon Communications
RBBN
$354M
| $56.2K | ﹤0.01% |
17,297
+5,399
| +45% | +$17.5K |
|
|
TRUE
1965
DELISTED
TrueCar
TRUE
| $55.8K | ﹤0.01% |
16,185
+4,189
| +35% | +$13.4K |
|
1966
Digital Turbine
APPS
$1.02B
| $55.7K | ﹤0.01% |
18,132
+5,175
| +40% | +$14K |
|
1967
Fulcrum Therapeutics
FULC
$248M
| $55K | ﹤0.01% |
+15,410
| New | +$114K |
|
1968
The Honest Company
HNST
$417M
| $54.9K | ﹤0.01% |
+15,384
| New | +$57.6K |
|
1969
SelectQuote
SLQT
$114M
| $54.9K | ﹤0.01% |
25,293
+7,017
| +38% | +$23K |
|
1970
Kodak
KODK
$806M
| $53.9K | ﹤0.01% |
+11,430
| New | +$59.5K |
|
1971
Sutro Biopharma
STRO
$379M
| $53.5K | ﹤0.01% |
1,547
-85
| -5% | -$3.33K |
|
1972
Oil States International
OIS
$522M
| $53.4K | ﹤0.01% |
+11,599
| New | +$55.6K |
|
1973
Cabaletta Bio
CABA
$439M
| $53.2K | ﹤0.01% |
+11,265
| New | +$65.2K |
|
|
ACCD
1974
DELISTED
Accolade Inc
ACCD
| $53.1K | ﹤0.01% |
+13,803
| New | +$54.1K |
|
1975
Akebia Therapeutics
AKBA
$327M
| $51.9K | ﹤0.01% |
+39,308
| New | +$52.5K |
|
Similar funds
ProShare Advisors's Q3 2024 Portfolio in Review
As of Q3 2024, ProShare Advisors held 2,151 positions worth $40.8B, up 9.2% from $37.4B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
ProShare Advisors's Q3 2024 filing shows 303 new, 1,108 increased, 653 reduced and 86 closed positions. Its largest new stake was NexPoint Residential Trust: 319,514 shares worth $14.1M. The largest sale was Qualcomm, an estimated $230M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 31% a quarter earlier, followed by Consumer Staples and Industrials.
- ProShare Advisors's largest Q3 2024 buy was NexPoint Residential Trust: 319,514 shares worth $14.1M.
- ProShare Advisors added most to West Pharmaceutical in Q3 2024, an estimated $197M increase.
- ProShare Advisors's biggest Q3 2024 reduction was Qualcomm, cutting an estimated $230M.
- ProShare Advisors fully exited Atrion Corp in Q3 2024, selling an estimated $8.02M.
- ProShare Advisors's ten largest holdings make up 25% of its $40.8B portfolio in Q3 2024.
- ProShare Advisors opened 303 new positions and closed 86 in Q3 2024.
- ProShare Advisors's portfolio value rose 9.2% quarter-over-quarter to $40.8B.
Based on ProShare Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.